Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma

Tune into our first episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.

Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma

Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.

Avalere 2021 Healthcare Industry Outlook: Clearing the Path

The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, careful examination of healthcare stakeholder’s business models, policy developments, and data will be essential to arrive at accurate assessments of the future state. Our experts engaged in a live discussion covering critical issues facing healthcare leaders and strategies for clearing the path.

Patient Health, Food Insecurity, and the Impact of Medically Tailored Meals

Tune into another episode of Avalere Health Essential Voice. In this segment, we are joined by experts from nutrition service organizations to discuss the impact of medically tailored meals (MTM) on health outcomes and healthcare costs, and future opportunities to expand their reach through health insurance plans.

COVID-19 Vaccine State Plans

Tune into another episode of Get the Facts on COVID-19. In this segment, our vaccines experts discuss state COVID-19 vaccine distribution plans, distribution challenges, and what this space might look like as the vaccines become more widely available.

What’s Next for Telehealth?

Tune into another episode of Start Your Day with Avalere. In this segment, our experts discuss the state of the telehealth sector, the issue of payment for virtual care, and the future of telehealth.

Social Determinants of Health: The Importance of Data, Part 2

Tune into the second segment of the Avalere Health Essential Voice podcast series focused on social determinants of health (SDOH) data. In this segment, Avalere experts discuss how life sciences organizations are beginning to recognize the importance and impact of this data, particularly in real-world evidence value demonstration work.

Social Determinants of Health: The Importance of Data, Part 2

Tune into the second segment of the Avalere Health Essential Voice podcast series focused on social determinants of health (SDOH) data. In this segment, Avalere experts discuss how life sciences organizations are beginning to recognize the importance and impact of this data, particularly in real-world evidence value demonstration work.

Social Determinants of Health: The Importance of Data, Part 1

In Part 1 of this segment focused on social determinants of health (SDOH), our experts from Avalere’s Health Economics and Advanced Analytics practice discuss the importance of SDOH data, how health plans are increasingly utilizing that data, and the ongoing limitations to data access.

Social Determinants of Health: The Importance of Data, Part 1

Tune into our fifth episode in the Avalere Health Essential Voice podcast series focused on social determinants of health (SDOH). In Part 1 of this segment, our experts from Avalere’s Health Economics and Advanced Analytics practice discuss the importance of SDOH data, how health plans are increasingly utilizing that data, and the ongoing limitations to data access.

Avalere 2021 Healthcare Industry Outlook: Clearing the Path

The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, careful examination of healthcare stakeholder’s business models, policy developments, and data will be essential to arrive at accurate assessments of the future state. Our experts engaged in a live discussion covering critical issues facing healthcare leaders and strategies for clearing the path.

For even deeper coverage, download the 2021 Healthcare Industry Outlook document below.

2020 Election with Avalere: COVID-19 Stakeholder Impacts

Tune into our seventh video of the Avalere Health Essential Voice: Election 2020 series. As election day approaches, our experts share their thoughts on how the COVID surge has changed the campaigns’ closing arguments, the current outlook on a COVID relief package, and how the election results will affect individual stakeholders.

2020 Election with Avalere: COVID-19 Stakeholder Impacts

Tune into our seventh episode of the Avalere Health Essential Voice: Election 2020 series. As election day approaches, our experts share their thoughts on how the COVID surge has changed the campaigns’ closing arguments, the current outlook on a COVID relief package, and how the election results will affect individual stakeholders.

Designing Pull Funding for a COVID-19 Vaccine

Tune into another episode of Avalere’s Journal Club Review podcast series on Avalere Health Essential Voice. In this segment, our health policy experts discuss a recent study in which a simulation was used to determine whether pull funding could overcome issues related to speed, scaling, and pricing for a COVID-19 vaccine.

Social Determinants of Health: The Role of the Health Plan

Tune into our fourth episode in the Avalere Health Essential Voice podcast series focused on social determinants of health (SDOH). In this segment, our experts discuss what health plans should know about SDOH data, specifically, the different types of data, what to do with them, and how to use them to fairly assess the impact of social risks on health outcomes.

Sign up to receive more insights about Federal and State Policy
Please enter your email address to be notified when new Federal and State Policy insights are published.

Back To Top